MDS Pharma

Crane joins SNBL USA

Monday, November 7, 2011 10:47 AM

More... »

Potthoff named president, CEO of Theorem Clinical Research

Wednesday, November 2, 2011 01:13 PM

John Potthoff has stepped down as chief operating officer of CRO INC Research to become president and CEO of Theorem Clinical Research, succeeding James Pusey, who now becomes Theorem’s executive chairman to the board of directors.

More... »

Cetero says FDA’s actions ‘difficult to understand’—company notified agency of chemists’ misconduct

Monday, August 1, 2011 08:02 AM

Large, early-phase CRO Cetero Research seemed blindsided by the FDA’s letter to the company last week accusing it of falsifying data and manipulating samples over a five-year period at its Houston bioanalytics lab.

More... »

Harlan names Manuela Leone president, CRS

Wednesday, April 27, 2011 12:01 PM

Global CRO Harlan Laboratories has appointed Dr. Manuela Leone as president of contract research services (CRS) for the company.

More... »

Firecrest Clinical Appoints New CEO

Thursday, May 20, 2010 09:06 AM

Firecrest Clinical, an eClinical solution provider, announces the appointment of Alan Horgan as CEO.

More... »

MDS Completes Sale of Discovery, Preclinical Portion of CRO

Tuesday, March 9, 2010 06:07 AM

MDS completed its sale of the discovery and preclinical business of MDS Pharma Services, the company’s contract research organization (CRO).  Under the terms of the deal, CRO Ricerca Biosciences of Concord, Ohio, acquired facilities in Bothell, Wash.; Lyon, France; and Taipei, Taiwan. Those facilities have 600 employees.

More... »

MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm

Wednesday, February 10, 2010 12:33 PM

MDS announced today plans to divide MDS Pharma Services, the company’s early-stage contract research organization (CRO), and sell it off to two separate companies for undisclosed amounts. The sale transactions are expected to close by April.

More... »

Czura Thornton to Buy MDS Central Lab Business

Monday, October 19, 2009 07:46 AM

Czura Thornton, the private investment group that already owns UK-based contract research organization (CRO) Chiltern International, has agreed to acquire the global central laboratory operations of MDS Pharma Services for about $8 million. 

More... »

Brazil Certifies MDS Pharma Services Early Clinical Facilities

Thursday, October 8, 2009 08:46 AM

MDS Pharma Services’ early clinical research and clinical pharmacology operations in Belfast, Northern Ireland, and its clinical pharmacology and bioanalytical services operation in Lincoln, Nebraska, have been certified by Brazil’s regulatory agency, Agencia Nacional de Vigilancia Sanitaria (ANVISA).

More... »

MDS Pharma Revenues Continue to Fall, Hunt for Buyer Continues

Friday, September 11, 2009 06:42 AM

Revenues continue to fall at MDS Pharma, the contract research arm of Toronto-based MDS. Third-quarter 2009 net revenues fell 28% from the same period last year, dropping to $49 million from $68 million. The year-over-year decline was a result of decreased demand for phase I and bioanalytical services, the company said.

More... »